Vir Biotechnology (VIR) Change in Account Payables (2018 - 2025)

Vir Biotechnology's Change in Account Payables history spans 8 years, with the latest figure at $3.0 million for Q4 2025.

  • On a quarterly basis, Change in Account Payables rose 252.63% to $3.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.0 million, a 605.77% increase, with the full-year FY2025 number at $5.0 million, up 605.77% from a year prior.
  • Change in Account Payables hit $3.0 million in Q4 2025 for Vir Biotechnology, up from -$5.4 million in the prior quarter.
  • Over the last five years, Change in Account Payables for VIR hit a ceiling of $8.9 million in Q2 2025 and a floor of -$7.5 million in Q3 2023.
  • Historically, Change in Account Payables has averaged $268350.0 across 5 years, with a median of -$99500.0 in 2023.
  • Biggest five-year swings in Change in Account Payables: tumbled 347.25% in 2021 and later surged 406.22% in 2025.
  • Tracing VIR's Change in Account Payables over 5 years: stood at $788000.0 in 2021, then surged by 255.33% to $2.8 million in 2022, then decreased by 6.18% to $2.6 million in 2023, then tumbled by 173.7% to -$1.9 million in 2024, then soared by 252.63% to $3.0 million in 2025.
  • Business Quant data shows Change in Account Payables for VIR at $3.0 million in Q4 2025, -$5.4 million in Q3 2025, and $8.9 million in Q2 2025.